Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1989 Feb;86(3):854–857. doi: 10.1073/pnas.86.3.854

Identification of androgen receptors in normal human osteoblast-like cells.

D S Colvard 1, E F Eriksen 1, P E Keeting 1, E M Wilson 1, D B Lubahn 1, F S French 1, B L Riggs 1, T C Spelsberg 1
PMCID: PMC286576  PMID: 2915981

Abstract

The sex steroids, androgens and estrogens, are major regulators of bone metabolism. However, whether these hormones act on bone cells through direct or indirect mechanisms has remained unclear. A nuclear binding assay recently used to demonstrate estrogen receptors in bone [Eriksen, E.F., Colvard, D.S., Berg, N.J., Graham, M.L., Mann, K.G., Spelsberg, T.C. & Riggs, B.L. (1988) Science 241, 84-86] was used to identify specific nuclear binding of a tritiated synthetic androgen, [3H]R1881 (methyltrienolone), in 21 of 25 (84%) human osteoblast-like cell strains and a concentration of bound steroid receptors of 821 +/- 140 (mean +/- SEM) molecules per cell nucleus. Binding was saturable and steroid-specific. Androgen receptor gene expression in osteoblasts was confirmed by RNA blot analysis. Relative concentrations of androgen and estrogen receptors were compared by measuring specific nuclear estrogen binding. Nuclear binding of [3H]estradiol was observed in 27 of 30 (90%) cell strains; the concentration of bound estradiol receptor was 1537 +/- 221 molecules per cell nucleus. The concentrations of nuclear binding sites were similar in males and females for both [3H]R1881 and [3H]estradiol. We conclude that both androgens and estrogens act directly on human bone cells through their respective receptor-mediated mechanisms.

Full text

PDF
854

Images in this article

856Image
on p.856

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aviv H., Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A. 1972 Jun;69(6):1408–1412. doi: 10.1073/pnas.69.6.1408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baran D. T., Bergfeld M. A., Teitelbaum S. L., Avioli L. V. Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif Tissue Res. 1978 Dec 8;26(2):103–106. doi: 10.1007/BF02013243. [DOI] [PubMed] [Google Scholar]
  4. Chen T. L., Feldman D. Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against the presence of estradiol receptors in rat bone. Endocrinology. 1978 Jan;102(1):236–244. doi: 10.1210/endo-102-1-236. [DOI] [PubMed] [Google Scholar]
  5. Chesnut C. H., 3rd, Ivey J. L., Gruber H. E., Matthews M., Nelp W. B., Sisom K., Baylink D. J. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism. 1983 Jun;32(6):571–580. doi: 10.1016/0026-0495(83)90027-6. [DOI] [PubMed] [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  7. Colvard D. S., Jankus W. R., Berg N. J., Graham M. L., 2nd, Jiang N. S., Ingle J. N., Spelsberg T. C. Microassay for nuclear binding of steroid receptors with use of intact cells from small samples of avian and human tissue. Clin Chem. 1988 Feb;34(2):363–369. [PubMed] [Google Scholar]
  8. Ekman P., Barrack E. R., Walsh P. C. Simultaneous measurement of progesterone and androgen receptors in human prostate: a microassay. J Clin Endocrinol Metab. 1982 Dec;55(6):1089–1099. doi: 10.1210/jcem-55-6-1089. [DOI] [PubMed] [Google Scholar]
  9. Eriksen E. F., Colvard D. S., Berg N. J., Graham M. L., Mann K. G., Spelsberg T. C., Riggs B. L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988 Jul 1;241(4861):84–86. doi: 10.1126/science.3388021. [DOI] [PubMed] [Google Scholar]
  10. Ernst M., Schmid C., Froesch E. R. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2307–2310. doi: 10.1073/pnas.85.7.2307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Genant H. K., Cann C. E., Ettinger B., Gordan G. S. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982 Nov;97(5):699–705. doi: 10.7326/0003-4819-97-5-699. [DOI] [PubMed] [Google Scholar]
  12. Gray T. K., Flynn T. C., Gray K. M., Nabell L. M. 17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6267–6271. doi: 10.1073/pnas.84.17.6267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Komm B. S., Terpening C. M., Benz D. J., Graeme K. A., Gallegos A., Korc M., Greene G. L., O'Malley B. W., Haussler M. R. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988 Jul 1;241(4861):81–84. doi: 10.1126/science.3164526. [DOI] [PubMed] [Google Scholar]
  14. Krabbe S., Hummer L., Christiansen C. Longitudinal study of calcium metabolism in male puberty. II. Relationship between mineralization and serum testosterone. Acta Paediatr Scand. 1984 Nov;73(6):750–755. doi: 10.1111/j.1651-2227.1984.tb17770.x. [DOI] [PubMed] [Google Scholar]
  15. Lindsay R., Hart D. M., Aitken J. M., MacDonald E. B., Anderson J. B., Clarke A. C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976 May 15;1(7968):1038–1041. doi: 10.1016/s0140-6736(76)92217-0. [DOI] [PubMed] [Google Scholar]
  16. Lubahn D. B., Joseph D. R., Sullivan P. M., Willard H. F., French F. S., Wilson E. M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science. 1988 Apr 15;240(4850):327–330. doi: 10.1126/science.3353727. [DOI] [PubMed] [Google Scholar]
  17. MacGillivray M. H., Kolotkin M., Munschauer R. W. Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone. Pediatr Res. 1974 Feb;8(2):103–108. doi: 10.1203/00006450-197402000-00006. [DOI] [PubMed] [Google Scholar]
  18. Meldrum D. R., Davidson B. J., Tataryn I. V., Judd H. L. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol. 1981 May;57(5):624–628. [PubMed] [Google Scholar]
  19. Mulvihill E. R., Palmiter R. D. Relationship of nuclear estrogen receptor levels to induction of ovalbumin and conalbumin mRNA in chick oviduct. J Biol Chem. 1977 Mar 25;252(6):2060–2068. [PubMed] [Google Scholar]
  20. Mulvihill E. R., Palmiter R. D. Relationship of nuclear progesterone receptors to induction of ovalbumin and conalbumin mRNA in chick oviduct. J Biol Chem. 1980 Mar 10;255(5):2085–2091. [PubMed] [Google Scholar]
  21. Riggs B. L., Jowsey J., Goldsmith R. S., Kelly P. J., Hoffman D. L., Arnaud C. D. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest. 1972 Jul;51(7):1659–1663. doi: 10.1172/JCI106967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Robey P. G., Termine J. D. Human bone cells in vitro. Calcif Tissue Int. 1985 Sep;37(5):453–460. [PubMed] [Google Scholar]
  23. Ross J. L., Cassorla F. G., Skerda M. C., Valk I. M., Loriaux D. L., Cutler G. B., Jr A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N Engl J Med. 1983 Nov 3;309(18):1104–1106. doi: 10.1056/NEJM198311033091806. [DOI] [PubMed] [Google Scholar]
  24. Spelsberg T. C., Graham M. L., 2nd, Berg N. J., Umehara T., Riehl E., Coulam C. B., Ingle J. N. A nuclear binding assay to assess the biological activity of steroid receptors in isolated animal and human tissues. Endocrinology. 1987 Aug;121(2):631–644. doi: 10.1210/endo-121-2-631. [DOI] [PubMed] [Google Scholar]
  25. Trachtenberg J., Walsh P. C. Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. J Urol. 1982 Mar;127(3):466–471. doi: 10.1016/s0022-5347(17)53868-9. [DOI] [PubMed] [Google Scholar]
  26. Walters M. R. Steroid hormone receptors and the nucleus. Endocr Rev. 1985 Fall;6(4):512–543. doi: 10.1210/edrv-6-4-512. [DOI] [PubMed] [Google Scholar]
  27. Yoshioka T., Sato B., Matsumoto K., Ono K. Steroid receptors in osteoblasts. Clin Orthop Relat Res. 1980 May;(148):297–303. [PubMed] [Google Scholar]
  28. van Paassen H. C., Poortman J., Borgart-Creutzburg I. H., Thijssen J. H., Duursma S. A. Oestrogen binding proteins in bone cell cytosol. Calcif Tissue Res. 1978 Aug 18;25(3):249–254. doi: 10.1007/BF02010778. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES